New York State Common Retirement Fund’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.1M | Hold |
2,088,390
| – | – | 0.01% | 908 |
|
|
2025
Q1 | $8.37M | Hold |
2,088,390
| – | – | 0.01% | 796 |
|
|
2024
Q4 | $13.6M | Hold |
2,088,390
| – | – | 0.02% | 629 |
|
|
2024
Q3 | $11.6M | Sell |
2,088,390
-860,618
| -29% | -$4.77M | 0.02% | 713 |
|
|
2024
Q2 | $16.5M | Buy |
2,949,008
+1,022
| +0% | +$5.7K | 0.02% | 589 |
|
|
2024
Q1 | $19.8M | Hold |
2,947,986
| – | – | 0.03% | 534 |
|
|
2023
Q4 | $26.9M | Buy |
2,947,986
+599,971
| +26% | +$5.47M | 0.04% | 410 |
|
|
2023
Q3 | $13M | Buy |
2,348,015
+700,701
| +43% | +$3.87M | 0.02% | 703 |
|
|
2023
Q2 | $14.1M | Buy |
1,647,314
+268,029
| +19% | +$2.29M | 0.02% | 721 |
|
|
2023
Q1 | $12.7M | Buy |
1,379,285
+552,162
| +67% | +$5.07M | 0.02% | 762 |
|
|
2022
Q4 | $8.45M | Buy |
827,123
+194,116
| +31% | +$1.98M | 0.01% | 956 |
|
|
2022
Q3 | $9.32M | Buy |
633,007
+561,521
| +785% | +$8.27M | 0.01% | 881 |
|
|
2022
Q2 | $767K | Buy |
71,486
+532
| +0.7% | +$5.71K | ﹤0.01% | 2160 |
|
|
2022
Q1 | $765K | Buy |
70,954
+60,125
| +555% | +$648K | ﹤0.01% | 2232 |
|
|
2021
Q4 | $177K | Buy |
10,829
+5,229
| +93% | +$85.5K | ﹤0.01% | 2915 |
|
|
2021
Q3 | $120K | Buy |
+5,600
| New | +$120K | ﹤0.01% | 3082 |
|